Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Healthcare Diagnostics & Research

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc > Q3 results

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Nov 28, 2024 9:18pm

64 Views

Post# 36336645

Q3 results

Qtr ending	Deployed	Lease & service	Products sold	Revenue	Gross Profit	Margin
Q3 24	784	596,075	599,047	1,195,122	434,791	36.4%
Q2 24	781	581,166	464,040	1,045,206	370,775	35.5%
Q1 24	775	563,487	560,820	1,124,307	484,791	43.1%
Q4 23	693	475,579	878,824	1,354,403	501,466	37.0%
Q3 23	635	406,119	547,335	953,454	261,778	27.5%
Q2 23	541	387,206	160,843	548,049	229,471	41.9%
Q1 23	532	311,001	318,240	629,241	210,681	33.5%
Q4 22	416	140,685	836,550	977,235	168,845	17.3%
Q3 22	166	52,290	519,938	572,228	215,961	37.7%
Q2 22	53	14,940	161,235	176,175	56,874	32.3%
Q1 22	53	14,491	28,245	42,736	15,113	35.4%